Elekta AB

STOCKHOLM SWEDEN, V7 · Medtech · Private

Radiotherapy systems and software for precision tumor targeting and treatment planning

Claim this profile

Follows are private to you and power your alerts

Updated · elekta.com

Sector
Medtech
Headquarters
STOCKHOLM SWEDEN, V7
Latest Form D
Oct 2012
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
first 2020
Rank in peer group#425 of 1112

Capital timeline

4 records are on file, but none carries both a date and an amount to place on a timeline.

Some award records list only a year, or report no amount. The figures above still reflect them where the source gives an amount.

Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards

Founder? Add funding context

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#425 · top 38%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • AKBAR SEDDIGHDirectorNamed in SEC Form D filings
  • ASA HEDINDirectorNamed in SEC Form D filings
  • BIRGITTA STYMNE GORANSSONDirectorNamed in SEC Form D filings
  • HAKEN BERGSTROMDirectorNamed in SEC Form D filings
  • HANS BARELLADirectorNamed in SEC Form D filings
  • IAN ALEXANDERDirectorNamed in SEC Form D filings
Show all 19 people
  • JAMES HOEYDirectorNamed in SEC Form D filings
  • JAN SECHERDirectorNamed in SEC Form D filings
  • JOHANNES BARELLADirectorNamed in SEC Form D filings
  • JOHAN SEDIHNDirectorNamed in SEC Form D filings
  • LAURENT LEKSELLDirectorNamed in SEC Form D filings
  • LUCIANO CATTANIDirectorNamed in SEC Form D filings
  • OLOF SANDENExecutive Officer, DirectorNamed in SEC Form D filings
  • SIAOU-SZE LIENDirectorNamed in SEC Form D filings
  • TODD POWELLDirectorNamed in SEC Form D filings
  • TOMAS PUUSEPPExecutive OfficerNamed in SEC Form D filings
  • TOMMY KARLSSONDirectorNamed in SEC Form D filings
  • VERA KALLMEYERDirectorNamed in SEC Form D filings
  • WOLFGANG REIMDirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 2
  • 3VO MEDICAL, INCSimilar federal contract value in Medtech · null in contracts
  • RED GENOMICS, INC.Similar federal contract value in Medtech · null in contracts
  • PRECISION SENSING LLCSimilar federal contract value in Medtech · null in contracts
  • ReValve Med, Inc.Similar federal contract value in Medtech · null in contracts
  • SPOT ON SCIENCES, LLCSimilar federal contract value in Medtech · null in contracts
  • DENOVX, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .